Cargando…

The future of immune checkpoint combinations with tumor-targeted small molecule drugs

Immune-checkpoint blockade (ICB) has transformed the landscape of cancer treatment. However, there is much to understand around refractory or acquired resistance in patients in order to utilize ICB therapy to its full potential. In this perspective article, we discuss the opportunities and challenge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sceneay, Jaclyn, Sinclair, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726049/ https://www.ncbi.nlm.nih.gov/pubmed/34196724 http://dx.doi.org/10.1042/ETLS20210064

Ejemplares similares

Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
por: Gillson, Josef, et al.
Publicado: (2020)

Immune checkpoint molecules: “new” kids on the block of skin photoimmunology
por: Wang, Wei, et al.
Publicado: (2019)

Small molecules to target tau amyloid aggregation
por: Manglano-Artuñedo, Zoe, et al.
Publicado: (2023)

Targeting RNA with small molecules: lessons learned from Xist RNA
por: Nickbarg, Elliott B., et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-related Endocrinopathies
por: Lu, Difei, et al.
Publicado: (2022)

Hallmarks of Resistance to Immune-Checkpoint Inhibitors
por: Karasarides, Maria, et al.
Publicado: (2022)

Targeting the Phosphatidylserine-Immune Checkpoint with a Small-Molecule Maytansinoid Conjugate
por: Lo, Chen-Fu, et al.
Publicado: (2022)

Managing cardiotoxicity associated with immune checkpoint inhibitors
por: Upadhrasta, Sireesha, et al.
Publicado: (2019)

Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
por: Fane, Lauren S., et al.
Publicado: (2022)

Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosis
por: Bose, Poulomee
Publicado: (2019)

Future Prospects of Immunotherapy in Non-Small-Cell Lung Cancer Patients: Is There Hope in Other Immune Checkpoints Targeting Molecules?
por: Krzyżanowska, Natalia, et al.
Publicado: (2022)

Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
por: Yu, Sheng, et al.
Publicado: (2021)

Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
por: Li, Ting-ting, et al.
Publicado: (2021)

The Who, Why, and How of Small-Molecule Production in Invertebrate Microbiomes: Basic Insights Fueling Drug Discovery
por: Kwan, Jason C.
Publicado: (2018)

HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
por: Morandi, Fabio, et al.
Publicado: (2022)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA
por: Bagnolini, Greta, et al.
Publicado: (2023)

Multi-faceted small molecule for Alzheimer’s disease
por: Park, Min Hee, et al.
Publicado: (2023)

Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer
por: Liebler, Daniel C., et al.
Publicado: (2020)

Sequential Treatment with an Immune Checkpoint Inhibitor Followed by a Small-Molecule Targeted Agent Increases Drug-Induced Pneumonitis
por: Jung, Jongheon, et al.
Publicado: (2021)

Immune checkpoint inhibitors in neuroendocrine tumors: A single institution experience with review of literature
por: Chauhan, Aman, et al.
Publicado: (2017)

Probing the Probes: Fitness Factors For Small Molecule Tools
por: Workman, Paul, et al.
Publicado: (2010)

Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials
por: Li, Bin, et al.
Publicado: (2023)

Targeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies
por: Gatzka, Martina V.
Publicado: (2018)

Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
por: Pan, Jing, et al.
Publicado: (2021)

Small molecules to prevent the neurodegeneration caused by α-synuclein aggregation
por: Peña-Díaz, Samuel, et al.
Publicado: (2020)

Targeting Immune Checkpoint Molecules to Eliminate Latent HIV
por: Boyer, Zoe, et al.
Publicado: (2018)

Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition
por: Sarkis, J., et al.
Publicado: (2021)

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
por: Gambichler, Thilo, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors and Mismatch Repair Status in Advanced Endometrial Cancer: Elective Affinities
por: Rizzo, Alessandro
Publicado: (2022)

Dearth of ICD Codes for Complications of Immune Checkpoint Inhibitors Impedes Clinical Care and Research
por: Cheung, Yee-Ming M, et al.
Publicado: (2023)

Is Open Science the Future of Drug Development?
por: Shaw, Daniel L.
Publicado: (2017)

Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
por: Martelletti, Paolo, et al.
Publicado: (2019)

Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response
por: Lin, Chia-Yi, et al.
Publicado: (2023)

Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors
por: Wu, Qiuyu, et al.
Publicado: (2023)

Modeling the tumor immune microenvironment for drug discovery using 3D culture
por: Lee, Joanna Y., et al.
Publicado: (2021)

Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors
por: Xavier, Camila B., et al.
Publicado: (2022)

Neoadjuvant checkpoint inhibition in non-small cell lung cancer: Is earlier unquestionably better than later?
por: Olivier, Timothée, et al.
Publicado: (2022)

Recent developments in one-pot stepwise synthesis (OPSS) of small molecules
por: Ma, Xiaoming, et al.
Publicado: (2022)

Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies
por: Tsuji, Ai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bjua1ug8qpq7qr3bm9o5vmnekr